The Study
Early Ezetimibe Initiation After Myocardial Infarction Protects Against Later Cardiovascular Outcomes in the SWEDEHEART Registry.
This study looked at medical records of thousands of people who had heart attacks and checked when they started taking ezetimibe. It found that people who started the drug sooner were less likely to have another heart problem, but we can't be sure the drug caused the difference because other factors might explain it.
Analysis score
Maximum 72 for a cohort study.
Where the score came from
After a heart attack, people usually take strong cholesterol pills called statins. Adding another pill called ezetimibe soon after helps lower bad cholesterol even more and protects the heart.
Where does this study sit?
Reviews of RCTs (Meta-analyses)
Max 100Randomized Trials
Max 90Reviews of Cohort Studies
Max 85Cohort Studies
Max 72Reviews of Case-Control Studies
Max 63Case-Control Studies
Max 58Cross-Sectional & Case Series
Max 50Expert Opinion
Max 559 / 100
Quality score
Groups of people are followed over time to see who develops an outcome. Strong for identifying risk factors and associations, but cannot prove causation as firmly as RCTs.
Key takeaways
Summary
Based on the study abstract and findings.
- 1Starting ezetimibe early cuts the risk of another heart problem nearly in half compared to not using it, which is a big deal for recovery and long-term heart health.
- 2Out of 35,826 people: 17% started ezetimibe early (within 12 weeks), 18% later, and 65% never.
- 3After one year, 1.8 out of 100 early users had heart problems, vs 2.6 in late users and 4 in those who didn’t use it.
Score breakdown, methodology, conflicts of interest, evidence analysis & raw study data
Publication
Journal
Journal of the American College of Cardiology
Year
2025
Authors
M. Leosdottir, J. Schubert, J. Brandts, S. Gustafsson, T. Cars, Johan Sundström, T. Jernberg, Kausik K. Ray, Emil Hagström
Related Content
Claims (6)
Ezetimibe helps lower bad cholesterol by stopping your gut from absorbing it, and even though it works well and doesn't cost much, doctors don't use it as much as they could.
If someone has a heart attack and hasn’t taken cholesterol drugs before, waiting more than 12 weeks to start a drug called ezetimibe might increase their risk of future heart problems — though the data isn’t strong enough to be sure.
If someone has a heart attack and starts taking a cholesterol drug called ezetimibe within 3 months, they’re less likely to have another heart problem in the next 3 years compared to those who wait longer or never start it.
If you've had a heart attack, starting a cholesterol drug called ezetimibe within 3 months might lower your chance of dying from heart problems over the next 3 years, compared to waiting or not taking it at all.
Out of nearly 36,000 people hospitalized for heart attacks, most didn't get a cholesterol drug called ezetimibe—even though almost all were already on strong statins. Only about 1 in 6 got it early, and a similar number got it later.
People who had a heart attack and started taking a cholesterol drug called ezetimibe early had fewer heart problems over the next year compared to those who started later or didn’t take it at all.
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.